Missing concentration [Study As­sess­ment]

posted by Sukalpa Biswas – India, 2020-07-13 13:51 (279 d 12:22 ago) – Posting: # 21682
Views: 506

» – What could be a point of investigation for the above case???? :-|

The investigation can be done clinically or bioanalytically.

Clinically, the after dosing activities, restrictions can be traced very closely by camera evidences. Any suspected activity need to be investigated/evaluated. One to one meeting with subject could be a part of clinical investigation.

Bioanalytically, the particular subject can be repeated with proper justification and documentation. Method, chromatographic and mass parameter must be checked for that particular batch. Hope samples from that subject included in ISR. ISR/Repeat data one of the conclusive evidences.

If still inconclusive, then can be done re dosing study depending upon consultation with the regulatory you are targeting for (if regulatory allows).

Complete thread:

 Admin contact
21,419 posts in 4,475 threads, 1,509 registered users;
online 14 (0 registered, 14 guests [including 1 identified bots]).
Forum time: Monday 02:13 CEST (Europe/Vienna)

There is one certainty in drug development
and statistics that one can depend on:
the data are always late.    Scott Patterson and Byron Jones

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz